Right ventricular failure following cardiac surgery

Coronary Artery Disease

Volumn 16, Issue 1, 2005, Pages 27-30

  Vlahakes, Gus J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardiac assist; Cardiac transplantation; Interventricular septum; Nitric oxide; Prostacyclin; Prostaglandin; Right ventricle; Right ventricular failure

Indexed keywords

HEART LEFT ATRIUM PRESSURE; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE;

ANIMALS; CARDIAC SURGICAL PROCEDURES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 14044251553     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200502000-00005     Document Type: Review

References (14)

1. Salsbury PF. Coronary artery pressure and strength of right ventricular contraction. Circ Res 1955; 3:633-638. A classic physiology experiment, the findings of which are the essence of managing RV failure in the modern practice.
2. Vlahakes GJ, Turley K, Hoffman JIE. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 1981; 63:87-95.
3. Page RD, Harringer W, Hodakowski GT, Guerrero JL, LaRaia PJ, Austen WG, et al. Determinants of maximal right ventricular function. J Heart Lung Transpl 1992; 11:90-98.
4. Klima U, Guerrero JL, Vlahakes GJ. Contribution of the interventricular septum to maximal right ventricular function. Eur J Cardiothorac Surg 1998; 14:250-255.
5. Klima UP, Myung-Yong L, Guerrero JL, LaRaia PJ, Levine RA, Vlahakes GJ. Determinants of maximal right ventricular function: role of septal shift. J Thorac Cardiovasc Surg 2002; 123:72-80.
6. Santini F, Gatti G, Borghetti V, Oppido G, Mazzucco A. Routine left atrial catheterization for the post-operative management of cardiac surgical patients: is the risk justified? Eur J Cardiothorac Surg 1999; 16:218-221.
7. D'Ambra MN, LaRaia PJ, Philbin DM, Watkins D, Hilgenberg AD, Buckley MJ. Prostaglandin E1: a new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg 1985; 89:567-572.
8. Said SI. Pulmonary metabolism of prostaglandins and vasoactive peptides. Ann Rev Physiol 1982; 44:257-268.
9. Lunn RJ. Inhaled nitric oxide therapy. Mayo Clin Proc 1995; 70:247-255.
10. Christenson J, Lavoie A, O'Connor M, Bhorade S, Pohlman A, Hall JB. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 2000; 161:1443-1449.
11. De Wet CJ, Affleck DG, Jacobsohn E, Avidan MS, Tymkew H, Hill LL, et al. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 2004; 127:1058-1067.
12. Lowson SM, Doctor A, Walsh BK, Doorley PA. Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery. Crit Care Med 2002; 30:2762-2764.
13. Santamore WP, Gray LA, Jr. Left ventricular contributions to right ventricular systolic function during LVAD support. Ann Thorac Surg 1996; 61:350-356.
14. Fukamachi K, McCarthy PM, Smedira NG, Vargo RL, Starling RC, Young JB. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 1999; 68:2181-2184.